down arrow

Guj. Terce Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE499G01013
  • NSEID:
  • BSEID: 524314
INR
62.39
2.17 (3.6%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 912

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

56.0162.98

52 Week

44.5294.90
Valuation
Technical
Day's Volume

CASH

912 (-48.22%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

37.03%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.08%

  • Poor long term growth as Net Sales has grown by an annual rate of 6.69% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 47 Cr (Micro Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.44

stock-summary
Return on Equity

33.30%

stock-summary
Price to Book

5.04

Revenue and Profits (1 Year):
Net Sales:
13 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-26.6%
0%
-26.6%
1 Year
7.7%
0%
7.7%
2 Years
234.71%
0%
234.71%
3 Years
109.01%
0%
109.01%
4 Years
679.88%
0%
679.88%
5 Years
922.79%
0%
922.79%

Guj. Terce Labs. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.69%
EBIT Growth (5y)
26.46%
EBIT to Interest (avg)
-0.35
Debt to EBITDA (avg)
1.09
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
3.76
Tax Ratio
9.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.64%
ROE (avg)
5.89%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
33
Price to Book Value
5.04
EV to EBIT
14.03
EV to EBITDA
12.67
EV to Capital Employed
3.82
EV to Sales
0.97
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
25.39%
ROE (Latest)
33.30%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Abundant Trade Link Private Limited (14.5%)

Highest Public shareholder

Sagar Saxena (1.21%)

Individual Investors Holdings

59.44%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -4.66% vs 11.86% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -31.76% vs 1,950.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.68",
          "val2": "13.30",
          "chgp": "-4.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.09",
          "val2": "1.66",
          "chgp": "-34.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.13",
          "chgp": "-38.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.01",
          "val2": "1.48",
          "chgp": "-31.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.60%",
          "val2": "12.48%",
          "chgp": "-3.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 10.73% vs 3.46% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 244.33% vs 60.73% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.19",
          "val2": "22.75",
          "chgp": "10.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.74",
          "val2": "-0.58",
          "chgp": "400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.37",
          "chgp": "-29.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.40",
          "val2": "-0.97",
          "chgp": "244.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.91%",
          "val2": "-2.55%",
          "chgp": "9.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 5.87% vs 5.55% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 903.33% vs 87.85% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.87",
          "val2": "35.77",
          "chgp": "5.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.83",
          "val2": "0.27",
          "chgp": "948.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.34",
          "val2": "0.53",
          "chgp": "-35.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.41",
          "val2": "-0.30",
          "chgp": "903.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.47%",
          "val2": "0.75%",
          "chgp": "6.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 2.54% vs 16.57% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 114.37% vs -291.95% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47.97",
          "val2": "46.78",
          "chgp": "2.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.26",
          "val2": "-2.17",
          "chgp": "158.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.68",
          "val2": "0.72",
          "chgp": "-5.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.24",
          "val2": "-1.67",
          "chgp": "114.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.63%",
          "val2": "-4.64%",
          "chgp": "7.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
12.68
13.30
-4.66%
Operating Profit (PBDIT) excl Other Income
1.09
1.66
-34.34%
Interest
0.08
0.13
-38.46%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.01
1.48
-31.76%
Operating Profit Margin (Excl OI)
8.60%
12.48%
-3.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -4.66% vs 11.86% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -31.76% vs 1,950.00% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
25.19
22.75
10.73%
Operating Profit (PBDIT) excl Other Income
1.74
-0.58
400.00%
Interest
0.26
0.37
-29.73%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.40
-0.97
244.33%
Operating Profit Margin (Excl OI)
6.91%
-2.55%
9.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 10.73% vs 3.46% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 244.33% vs 60.73% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
37.87
35.77
5.87%
Operating Profit (PBDIT) excl Other Income
2.83
0.27
948.15%
Interest
0.34
0.53
-35.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.41
-0.30
903.33%
Operating Profit Margin (Excl OI)
7.47%
0.75%
6.72%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 5.87% vs 5.55% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 903.33% vs 87.85% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
47.97
46.78
2.54%
Operating Profit (PBDIT) excl Other Income
1.26
-2.17
158.06%
Interest
0.68
0.72
-5.56%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.24
-1.67
114.37%
Operating Profit Margin (Excl OI)
2.63%
-4.64%
7.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 2.54% vs 16.57% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 114.37% vs -291.95% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Gujarat Terce Laboratories Ltd stock-summary
stock-summary
Gujarat Terce Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market. Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states.
Company Coordinates stock-summary
Company Details
122/2 Ravi Estate, Bileshwarpura Chhatral Gandhinagar Gujarat : 382729
stock-summary
Tel: 91-079-6663 3706
stock-summary
http://www.gujaratterce.com
stock-summary
ho@gujaratterce.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."